Tilia Fiduciary Partners’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-183
Closed -$5K 567
2022
Q1
$5K Hold
183
﹤0.01% 471
2021
Q4
$7K Buy
+183
New +$7K 0.01% 445